BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 9, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2009
View Archived Issues
Inhibitors of epithelial cancer stem cells identified with innovative screen
Read More
Snapshots of studies of CXA-101 alone and in combination with tazobactam presented at ICAAC: II
Read More
Discouraging results reported for bone agent ronacaleret
Read More
IPA-3 covalently binds to the regulatory domain of PAK1; new approach for kinase inhibition revealed
Read More
Bazedoxifene acetate is safe, tolerated and cost-effective in osteoporotic postmenopausal women
Read More
Toremifene prevents bone loss and increases bone mass density in androgen-deprived males
Read More
Adenovirus-based gene therapy restores trichromatic vision in adult color-blind primates
Read More
Novel IGF-I receptor antagonists identified by US scientists for the treatment of cancer
Read More
Roche claims alpha1A-adrenoceptor partial agonists for the treatment of urinary incontinence
Read More
Naphthoquinone derivatives for the treatment of leishmaniasis described by German scientists
Read More
Abbott describes positive allosteric modulators of alpha7 nicotinic receptor as analgesics
Read More
Adolor acquires rights to OpRA III from Lilly
Read More
AstraZeneca and Nektar Therapeutics sign agreement for drug development programs
Read More
Cell Therapeutics will focus resources on the approval of Opaxio for ovarian cancer
Read More
Neuralstem cleared to commence stem cell trial in amyotrophic lateral sclerosis
Read More
Sabril launched in U.S. for patients with difficult-to-treat epilepsy
Read More
Takeda San Francisco enters into sponsored research agreement with UCSF
Read More
Valeant advances retigabine program
Read More
Viralytics completes phase I melanoma trial and prepares for phase II
Read More
Abbott receives FDA approval for HIV-1/HIV-2 blood screening test
Read More
Genomica launches diagnostic kit for H1N1
Read More
Celera and Medco evaluate effect of KIF6 testing on statin therapy compliance
Read More
Kevetrin delays tumor growth in animal models of drug-resistant breast cancer
Read More
Lux Biosciences reports phase I safety and efficacy results for LX-214
Read More
Janssen-Cilag's Stelara approved in UK for plaque psoriasis
Read More
Modest positive results reported from phase III clinical trial in Thailand of HIV vaccine
Read More
